Standard BioTools Inc.
LAB • NASDAQ
Standard BioTools Inc. is a medical - diagnostics & research company in the healthcare sector trading on NASDAQ, led by CEO Michael Egholm, with a market cap of $355.4M.
Market Cap$355.4M
Employees539.0
CEOMichael Egholm
CountryUnited States of America
Healthcare
Medical - Diagnostics & Research
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026
Financials
LAB
Standard BioTools Inc. FAQ
Common questions about Standard BioTools Inc.
Standard BioTools Inc. is scheduled to report earnings for Q1 2026 on May 5, 2026. Analysts estimate revenue of $17.7M.
Standard BioTools Inc. has approximately 539 employees.